Patent ID: 7713702

Claim:
A method of determining a likelihood that a test subject has schizophrenia as opposed to being healthy, said method comprising: (a) for each gene of a set of genes consisting of ABOBEC3B, ADSS, ATM, CLC, CTBP1, CXCL1, DATF1 and S100A9, determining a level of RNA encoded by said gene in a blood sample of said test individual, thereby obtaining test levels of RNA; and (b) applying to said test levels a classifier for determining a likelihood that a level of RNA encoded by said gene, for each gene of said set of genes, in blood of a subject corresponds to a level of RNA encoded by said gene, for each gene of said set of genes, in blood of subjects having schizophrenia as opposed to a level of RNA encoded by said gene, for each gene of said set of genes, in blood of healthy subjects, wherein said classifier is derived from a level of RNA encoded by said gene, for each gene of said set of genes, in blood of subjects having schizophrenia and a level of RNA encoded by said gene, for each gene of said set of genes, in blood of healthy subjects, thereby determining a likelihood that a test subject has schizophrenia as opposed to being healthy.